ASCO® 2024 Insights: "TRANSFORM Study - 3-Year Follow-Up Comparing Liso-Cel vs. SoC With Salvage Chemo and ASCT as 2L Treatment in R/R LBCL" | VuMedi

Find latest DLBCL videos · 200+ videos

Video Player is loading.

Current Time 0:00

Duration 8:04

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "TRANSFORM Study - 3-Year Follow-Up Comparing Liso-Cel vs. SoC With Salvage Chemo and ASCT as 2L Treatment in R/R LBCL"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Manali Kamdar

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Manali Kamdar

90 views

June 20, 2024

Comments 0

Login to view comments. Click here to Login